Veterinary Medicines

Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs

Authorised
  • Milbemycin oxime
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs
Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog (large)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    25.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    25.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1 box with 1 blister, each blister contains 2 chewable tablets
  • 1 box with 2 blisters, each blister contains 2 chewable tablets
  • 1 box with 12 blisters, each blister contains 2 chewable tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 19(1) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA25201/001/003
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0413/003
Concerned member states:
  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)